One third of middle ear effusions from children undergoing tympanostomy tube placement had multiple bacterial pathogens
© Holder et al.; licensee BioMed Central Ltd. 2012
Received: 21 November 2011
Accepted: 18 June 2012
Published: 28 June 2012
Because previous studies have indicated that otitis media may be a polymicrobial disease, we prospectively analyzed middle ear effusions of children undergoing tympanostomy tube placement with multiplex polymerase chain reaction for four otopathogens.
Middle ear effusions from 207 children undergoing routine tympanostomy tube placement were collected and were classified by the surgeon as acute otitis media (AOM) for purulent effusions and as otitis media with effusion (OME) for non-purulent effusions. DNA was isolated from these samples and analyzed with multiplex polymerase chain reaction for Haemophilus influenzae, Streptococcus pneumoniae, Alloiococcus otitidis, and Moraxella catarrhalis.
119 (57%) of 207 patients were PCR positive for at least one of these four organisms. 36 (30%) of the positive samples indicated the presence of more than one bacterial species. Patient samples were further separated into 2 groups based on clinical presentation at the time of surgery. Samples were categorized as acute otitis media (AOM) if pus was observed behind the tympanic membrane. If no pus was present, samples were categorized as otitis media with effusion (OME). Bacteria were identified in most of the children with AOM (87%) and half the children with OME (51%, p < 0.001). A single bacterial organism was detected in middle ear effusions from children with AOM more often than those with OME (74% versus 33%, p < 0.001). Haemophilus influenzae was the predominant single organism and caused 58% of all AOM in this study. Alloiococcus otitidis and Moraxella catarrhalis were more frequently identified in middle ear effusions than Streptococcus pneumoniae.
Haemophilus influenzae, Streptococcus pneumoniae, Alloiococcus otitidis, and Moraxella catarrhalis were identified in the middle ear effusions of some patients with otitis media. Overall, we found AOM is predominantly a single organism infection and most commonly from Haemophilus influenzae. In contrast, OME infections had a more equal distribution of single organisms, polymicrobial entities, and non-bacterial agents.
Otitis media is one of the most common childhood diseases . Acute otitis media (AOM) typically exhibits rapid-onset purulent middle ear effusion and symptoms of middle ear inflammation, including fever and otalgia , whereas otitis media with effusion (OME) exhibits non-purulent middle ear effusion in the absence of symptoms of acute infection . Otitis media is the leading reason for pediatric office visits and for antibiotic prescriptions . The economic burden of otitis media in the United States is estimated at $3–5 billion in direct annual costs [5, 6], and much higher if indirect costs such as lost working days and loss of productivity by family members caring for the sick are included .
A common treatment for frequent AOM and for persistent OME with hearing loss is the insertion of tympanostomy tubes. Insertion of tympanostomy tubes is the most common surgical procedure excluding circumcision for U.S. children ≤15 years of age [8, 9]. Parents of children who have undergone tympanostomy tube placement report an increased quality of life due to the elimination of AOM symptoms and improved hearing and speech .
The bacterial pathogens most commonly cultured from the middle ear effusions of children with AOM are H. influenzae, S. pneumoniae, and M. catarrhalis[11, 12]. Although routine bacterial cultures have been the conventional method to identify the etiology of AOM, approximately 35% of these bacterial cultures are negative [13–15]. Polymerase chain reaction (PCR) has detected bacterial DNA in culture-negative middle ear effusions [16, 17]. PCR not only provides a more sensitive method for identifying MEE pathogens, but it also allows for the identification of fastidious or slow-growing organisms. For example, A. otitidis, a pathogen first isolated from middle ear effusions of children with OME , was more recently identified because its slow growth characteristics are not conducive to identification using conventional bacterial culture methods . The sensitivity of PCR has lead to a growing recognition that otitis media may be a polymicrobial disease . Here we used a multiplex PCR to determine the prevalence of four known otopathogens (H. influenzae, S. pneumoniae, A. otitidis, and M. catarrhalis) in the middle ear effusions of children undergoing routine tympanostomy placement.
Patients and sample collection
Effusion samples were collected from all children (< 18 y) who had tympanostomy tube placement for clinical indications at Wake Forest School of Medicine from July 2009 through December 2010 provided middle ear fluid was present at the time of surgery. The principle pre-operative diagnoses were recurrent acute otitis media and chronic otitis media with effusion. These are the two principle indications for which children undergo myringotomy and tympanostomy tube placement. The children from whom samples were collected are representative of all children who undergo myringotomy and tympanostomy tube placement at Wake Forest. This study was reviewed and approved by the Wake Forest School of Medicine Institutional Review Board as an exempt study; no personal health information was collected and discarded samples of middle ear effusions were evaluated for bacterial pathogens.
Children who at the time of tympanostomy tube placement had middle ear effusions had that fluid aspirated into a sterile trap. Middle ear effusion samples were categorized as AOM or OME by the surgeon at the time of tympanostomy tube placement. AOM was diagnosed by the identification of purulent fluid behind the tympanic membrane upon myringotomy. OME was defined as non-purulent fluid behind the tympanic membrane. All middle ear effusion samples were kept at room temperature and transported to the research laboratory within 2 h. Samples were then refrigerated at 4°C until DNA isolation. All data was prospectively acquired. While a formal blind was not used, specimen processing was done without prior record review. Once samples were collected, surgeons were not involved in specimen processing.
Isolation of DNA
For the few effusions that were very viscous, they were placed in Lysing Matrix D tubes (MP Biomedical, Solon, OH) with 500μL of 1X TE buffer (pH 7.5). The lysing tubes were processed in a FastPrep FP120 homogenizer (Thermo Electron Corporation, Milford, MA) for 40 s on a setting of 6.0. Processed samples were centrifuged at 12000 rpm for 5 min and 200μL of supernatant were used as the starting material for genomic DNA extraction.
DNA was isolated from middle ear effusions using a conventional genomic DNA extraction protocol. First, 200μL of effusion were treated with 15μL of Mutanolysin (10U/μL; Sigma, St. Louis, MO) and 21μL of Lysozyme (20 mg/mL; Amresco, Solon, OH) and then incubated at 37°C for 1 h. Second, samples were treated with 55μL of 10% SDS (EMD, Gibbstown, NJ) and 68μL of RNAse A (Sigma, St. Louis, MO) and then incubated at 37°C for 1 h. Third, samples were treated with 10μL of Proteinase K (10 mg/mL; Amresco, Solon, OH) and then incubated at 37°C for 1 h. Fourth, samples were treated with 55μL of 5 M NaCl (Sigma, St. Louis, MO) and 50μL of prewarmed (to 60°C) 10% Hexadecyltrimethyl-ammonium bromide (Sigma, St. Louis, MO) and then incubated at 60°C for 20 min. Fifth, samples were mixed with 470μL of Phenol:Chloroform:Isoamyl Alcohol (25:24:1; Sigma, St. Louis, MO) and transferred to prespun Phase Lock Tubes (2 mL, heavy; 5 Prime, Gaithersburg, MD). Tubes were centrifuged for 5 min at 12000 rpm, and the upper (aqueous) layer from each sample was transferred to a sterile 1.5 mL microcentrifuge tube. Aqueous layers were mixed with 50μL of 3 M NaOAc (Sigma, St. Louis, MO) and 470μL of ice cold 100% Ethanol (Warner-Graham, Cockeysville, MD). Samples were incubated at −20°C for a minimum of 30 min. Precipitated samples were centrifuged for 30 min at 12000 rpm at 4°C. Supernatants were discarded and pellets washed with 1 mL of 70% Ethanol. Pellets were allowed to completely dry and were resuspended in a final volume of 100μL of dH2O.
Polymerase chain reaction
Primers used in multiplex PCR
Predicted Amplicon Sizea
H. influenzae FWD
525 base pairs
S. pneumoniae FWD
484 base pairs
A. otitidis FWD
264 base pairs
M. catarrhalis FWD
237 base pairs
The demographic characteristics, current medications, and past medical history were all determined by chart review performed at the time of surgery without collecting any personal health identifiers. The pediatric otolaryngologist used a standardized clinical form that elicited all of this clinical information by history and/or by documentation from the primary care provider. Previous antibiotics were documentation of any course of antibiotics within 6 months of surgery.
The frequency of demographic characteristics, clinical characteristics, or microbiologic results of children with AOM and OME middle ear effusions were compared using chi-square analyses or Fisher’s exact tests. For the children who had middle ear effusions in both ears, the results from each ear were combined so that all children with one or two middle ear effusions had one result. Identification of purulence in the effusion of at least one ear was used as a basis for categorizing the sample as AOM. STATA 8.1 was used for all statistical analyses.
No. of Children (column %) (n = 207)
No. of Children (column %) (n = 38)
No. of Children (column %) (n = 169)
Currently on Antibioticsa
Currently on Allergy Medicinesb
Previous Ear Infections
Previously on Antibioticsc
Previous Ear Tubes
Incidence of bacterial DNA presence in Middle Ear Effusions
Presence of Bacterial DNA
No. of Children (column %) (n = 38)
No. of Children (column %) (n = 169)
No Bacteria Detected
For middle ear effusions with a single bacterial species identified, the etiology for children with AOM differed significantly from those with OME (p < 0.001). H. influenzae accounted for 79% of the isolates from children with AOM, whereas three bacteria accounted for the majority of isolates for children with OME: H .influenzae for 36%, A. otitidis for 40% and M. catarrhalis for 20%. S. pneumoniae was detected in 5% of all isolates for children with AOM and OME. Alloiococcus otitidis was identified either as a single organism or as a polymicrobial component in 18% of AOM and 25% of OME. All four bacteria were identified in at least one of the middle ear effusions with AOM or OME.
Using a multiplex PCR to simultaneously detect four bacterial otopathogens in the middle ear effusions obtained from children undergoing routine tympanostomy tube placement, we found distinct bacterial profiles for AOM and OME. Bacteria were identified in most of the children with AOM (87%) and half the children with OME (51%, p < 0.001). A single bacterial organism was detected in middle ear effusions from patients with AOM more often than those with OME (74% versus 33%, p < 0.001). Haemophilus influenzae was the predominant single organism and caused 58% of all AOM in this study. Alloiococcus otitidis and Moraxella catarrhalis were more frequently identified in middle ear effusions than Streptococcus pneumoniae.
Overall, we found AOM is predominantly a single organism infection, whereas, OME infections had a more equal distribution of single organisms, polymicrobial entities, and non-bacterial agents.
H. influenzae was the predominant bacterial species identified, comprising 66% (25 of 38) of middle ear effusions with AOM and 24% (40 of 169) of middle ear effusions with OME. We observed a higher proportion of samples with H. influenzae and a lower proportion with S. pneumoniae than what has been previously reported. Kaur et al., using a similar multiplex PCR approach on AOM middle ear effusion, detected H. influenzae in 31% of children who were on antibiotic prior to sample acquisition and 39% in children who had not undergone antibiotic treatment . However, Kaur et al. utilized specifically culture-negative MEF, a distinction we have not made with the samples obtained for our research. In other work using culture-negative AOM MEE samples, Xu et al. observed an H. influenzae percentage of 24% .
While the levels of H. influenzae in our patients appear to be higher than what others have seen, we observed the opposing trend with respect to S. pneumoniae. S. pneumoniae, regarded as one of the 3 most prevalent bacterial contributors to OM infection, was identified in only 2 of 38 AOM patients (~5%) and 8 of 169 OME patients (~5%). In the studies listed above by Kaur et al. and Xu et al., S. pneumoniae was identified in around 38%–57% of culture-negative AOM MEF samples, percentages that are considerably higher than what was observed in our study [13, 21].
A number of factors may explain our finding that S. pneumoniae was detected in only 5% of all study subjects. Published studies of pneumococcal prevalence in otitis media report a wide incidence range. Brooke et al. used standard culture based techniques to detect S. pneumoniae in approximately 16% of OME effusions . Post et al. used PCR to detect S. pneumoniae in OME effusions at a higher percentage of approximately 30% . Research conducted by Hendolin et al. detected S. pneumoniae in only 8% of cases examined . We used the same multiplex PCR primers used by Hendolin et al. Kaur et al. used these PCR primers to identify S. pneumoniae in approximately 57% of effusions from children with AOM , and this data does not suggest that our PCR assay has a low sensitivity for detection of pneumococcus.
The low S. pneumoniae incidence found in our study might be explained by the effectiveness of pneumococcal conjugate vaccination. A heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in 2000, and since its acceptance for widespread use there has been a shift in the incidence of otitis media pathogens. In the years immediately following PCV7 introduction, H. influenzae emerged as the most common AOM isolate [14, 24]. More recently, S. pneumoniae serotypes not included in the PCV7 vaccine have been increasingly isolated from AOM cases . In 2010, a new modified pneumococcal conjugate vaccine was introduced to combat the emergence of S. pneumoniae serotypes not included in the original PCV7 vaccine. It contained components from 13 serotypes of S. pneumoniae (7 serotypes included in the PCV7 vaccine along with 6 recently emerging serotypes). Our findings are consistent with improved pneumococcal vaccine prevention in children enrolled in this study.
Another interesting result was the high incidence of A. otitidis in our OME samples (approximately 25%, single and co-infections included). A. otitidis was first identified in OME samples by Faden et al. . It is a Gram-positive organism that exhibits very slow growth, making it very difficult to identify through standard culture techniques. It has been thought of as solely an OME pathogen; however, it is increasingly recognized as a pathogen in AOM [13, 25, 26]. Our findings support what has been reported previously in OME cases . The A. otitidis results further demonstrate the importance of using methods other than standard culture for the identification of fastidious otopathogens.
In conclusion, the etiology of OM appears to revolve around disease type (AOM or OME). A multiplex PCR approach may be used to identify specific bacterial DNA species in effusions from children experiencing OM. The PCR procedures can overcome the obstacles of culturing fastidious organisms, and may offer a more sensitive and time efficient method for evaluating middle ear effusions. While our approach targeted 4 organisms, the method could be adapted for the identification of additional microorganisms.
Our criterion for separating AOM cases from OME cases was the presence of pus behind the tympanic membrane at the time of tympanostomy tube placement. The results of our research clearly show that this single easily observable patient difference was sufficient to categorize disease condition into 2 distinct populations. Moreover, our results indicate that when AOM is observed there is usually a single bacterial etiology. Culture or PCR analysis of pus at tympanostomy tube placement may be especially useful in guiding antibiotic therapy.
RCH participated in the design of the study, experimental procedures, data analysis, and manuscript preparation. DJK and AKE participated in the design of the study, sample collection surgeries, data analysis, and manuscript preparation. TRP, KAP, and WES participated in the design of the study, data analysis, and manuscript preparation. SDR participated in the design of the study, experimental procedures, data analysis, and manuscript preparation. All authors gave final approval of the completed manuscript.
We would like to thank Mrs. Tina Swords and Miss Amy Braden for their contributions to the project. This project was supported by R01 DC010051-03 from the National Institutes of Health to WES and SDR. This funding body had no role in the design of the study, data analysis, manuscript preparation, or decision to submit the manuscript for publication.
- Bluestone CD: Studies in otitis media: Children’s Hospital of Pittsburgh-University of Pittsburgh progress report–2004. Laryngoscope. 2004, 114: 1-26.View ArticlePubMed
- Subcommittee on Management of Acute Otitis Media: Diagnosis and management of acute otitis media. Pediatrics. 2004, 113: 1451-1465.View Article
- Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR, et al: Clinical practice guideline: Otitis media with effusion. Otolaryngol Head Neck Surg. 2004, 130: S95-S118. 10.1016/j.otohns.2004.02.002.View ArticlePubMed
- Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman SL, Higham M, Miller Z, Miroshnik I, Pedan A, et al: Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001, 108: 1-7. 10.1542/peds.108.1.1.View ArticlePubMed
- Bondy J, Berman S, Glazner J, Lezotte D: Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics. 2000, 105: E72-10.1542/peds.105.6.e72.View ArticlePubMed
- Schwartz SR, Gates GA: Economic costs. Evidence-based Otitis Media. Edited by: Bluestone CD, Rosenfeld RM. 2003, Hamilton: BC Decker Inc, 333-341. 2
- Rovers MM: The burden of otitis media. Vaccine. 2008, 26 (Suppl 7): G2-G4.View ArticlePubMed
- Kogan MD, Overpeck MD, Hoffman HJ, Casselbrant ML: Factors associated with tympanostomy tube insertion among preschool-aged children in the United States. Am J Public Health. 2000, 90: 245-250.PubMed CentralView ArticlePubMed
- Pokras R, Kozak L, McCarthy E: Ambulatory and inpatient procedures in the United States, 1994. Vital Health Stat. 1994, 13: 11-17.
- Rosenfeld RM, Bhaya MH, Bower CM, Brookhouser PE, Casselbrant ML, Chan KH, Cunningham MJ, Derkay CS, Gray SD, Manning SC, et al: Impact of tympanostomy tubes on child quality of life. Arch Otolaryngol Head Neck Surg. 2000, 126: 585-592.View ArticlePubMed
- Giebink GS: The microbiology of otitis media. Pediatr Infect Dis J. 1989, 8: S18-S20. 10.1097/00006454-198901001-00007.View ArticlePubMed
- Casey JR, Adlowitz DG, Pichichero ME: New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010, 29: 304-309.PubMed CentralPubMed
- Kaur R, Adlowitz DG, Casey JR, Zeng M, Pichichero ME: Simultaneous assay for four bacterial species including Alloiococcus otitidis using multiplex-PCR in children with culture negative acute otitis media. Pediatr Infect Dis J. 2010, 29: 741-745. 10.1097/INF.0b013e3181d9e639.PubMed CentralView ArticlePubMed
- Casey JR, Pichichero ME: Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J. 2004, 23: 824-828. 10.1097/01.inf.0000136871.51792.19.View ArticlePubMed
- Jacobs MR, Dagan R, Appelbaum PC, Burch DJ: Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998, 42: 589-595.PubMed CentralPubMed
- Hotomi M, Tabata T, Kakiuchi H, Kunimoto M: Detection of Haemophilus influenzae in middle ear of otitis media with effusion by polymerase chain reaction. Int J Pediatr Otorhinolaryngol. 1993, 27: 119-126. 10.1016/0165-5876(93)90127-O.View ArticlePubMed
- Ueyama T, Kurono Y, Shirabe K, Takeshita M, Mogi G: High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR. J Clin Microbiol. 1995, 33: 1835-1838.PubMed CentralPubMed
- Faden H, Dryja D: Recovery of a unique bacterial organism in human middle ear fluid and its possible role in chronic otitis media. J Clin Microbiol. 1989, 27: 2488-2491.PubMed CentralPubMed
- Pettigrew MM, Gent JF, Pyles RB, Miller AL, Nokso-Koivisto J, Chonmaitree T: Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol. 2011, 49: 3750-3755. 10.1128/JCM.01186-11.PubMed CentralView ArticlePubMed
- Hendolin PH, Markkanen A, Ylikoski J, Wahlfors JJ: Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions. J Clin Microbiol. 1997, 35: 2854-2858.PubMed CentralPubMed
- Xu Q, Kaur R, Casey JR, Adlowitz DG, Pichichero ME, Zeng M: Identification of Streptococcus pneumoniae and Haemophilus influenzae in culture-negative middle ear fluids from children with acute otitis media by combination of multiplex PCR and multi-locus sequencing typing. Int J Pediatr Otorhinolaryngol. 2011, 75: 239-244. 10.1016/j.ijporl.2010.11.008.PubMed CentralView ArticlePubMed
- Brook I, Yocum P, Shah K, Feldman B, Epstein S: Microbiology of serous otitis media in children: correlation with age and length of effusion. Ann Otol Rhinol Laryngol. 2001, 110: 87-90.View ArticlePubMed
- Post JC, Preston RA, Aul JJ, Larkins-Pettigrew M, Rydquist-White J, Anderson KW, Wadowsky RM, Reagan DR, Walker ES, Kingsley LA, et al: Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA. 1995, 273: 1598-1604. 10.1001/jama.1995.03520440052036.View ArticlePubMed
- Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E: Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004, 23: 829-833. 10.1097/01.inf.0000136868.91756.80.View ArticlePubMed
- Leskinen K, Hendolin P, Virolainen-Julkunen A, Ylikoski J, Jero J: Alloiococcus otitidis in acute otitis media. Int J Pediatr Otorhinolaryngol. 2004, 68: 51-56. 10.1016/j.ijporl.2003.09.005.View ArticlePubMed
- Harimaya A, Takada R, Hendolin PH, Fujii N, Ylikoski J, Himi T: High incidence of Alloiococcus otitidis in children with otitis media, despite treatment with antibiotics. J Clin Microbiol. 2006, 44: 946-949. 10.1128/JCM.44.3.946-949.2006.PubMed CentralView ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/12/87/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.